IRAK inhibitors and uses thereof
US8703941B2 · kind B2 · utility
12Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2012 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Jan 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides thienopyrimidine and thienopyridine compounds, compositions thereof, and methods of using the same for the treatment of diseases mediated by IRAK enzymes. Such diseases include inflammatory and proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.